Detailed View
SLN - Silence Therapeutics Plc - Amer
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
545,559,808
Adj EBIT (TTM)
-78,405,000
Enterprise Value
475,481,808
Last Price
11.55
Earnings Yield
-16.49%
Return on Capital
-83.14%
Capital
94,305,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 422,000 | -15,737,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 58,000 | -12,461,000 |
| 2025-09-30 | 10-Q | 2025 | 159,000 | -26,244,000 |
| 2025-06-30 | 10-Q | 2025 | 200,000 | -23,963,000 |
| 2025-03-31 | 10-Q | 2025 | 142,000 | -28,409,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.